Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP270215.RA-w-n_YRnJRSZCHNS_m2LqVuPnizX-ziNKVZivZ3jTDo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP270215.RA-w-n_YRnJRSZCHNS_m2LqVuPnizX-ziNKVZivZ3jTDo130_assertion type Assertion NP270215.RA-w-n_YRnJRSZCHNS_m2LqVuPnizX-ziNKVZivZ3jTDo130_head.
- NP270215.RA-w-n_YRnJRSZCHNS_m2LqVuPnizX-ziNKVZivZ3jTDo130_assertion description "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270215.RA-w-n_YRnJRSZCHNS_m2LqVuPnizX-ziNKVZivZ3jTDo130_provenance.
- NP270215.RA-w-n_YRnJRSZCHNS_m2LqVuPnizX-ziNKVZivZ3jTDo130_assertion evidence source_evidence_literature NP270215.RA-w-n_YRnJRSZCHNS_m2LqVuPnizX-ziNKVZivZ3jTDo130_provenance.
- NP270215.RA-w-n_YRnJRSZCHNS_m2LqVuPnizX-ziNKVZivZ3jTDo130_assertion SIO_000772 23393682 NP270215.RA-w-n_YRnJRSZCHNS_m2LqVuPnizX-ziNKVZivZ3jTDo130_provenance.
- NP270215.RA-w-n_YRnJRSZCHNS_m2LqVuPnizX-ziNKVZivZ3jTDo130_assertion wasDerivedFrom befree-20140225 NP270215.RA-w-n_YRnJRSZCHNS_m2LqVuPnizX-ziNKVZivZ3jTDo130_provenance.
- NP270215.RA-w-n_YRnJRSZCHNS_m2LqVuPnizX-ziNKVZivZ3jTDo130_assertion wasGeneratedBy ECO_0000203 NP270215.RA-w-n_YRnJRSZCHNS_m2LqVuPnizX-ziNKVZivZ3jTDo130_provenance.